Welcome to the Towers Lab





We aim to understand the molecular details of host virus interactions, to develop novel therapeutic approaches for viral infection and to use viruses to help us understand mammalian cell biology and evolution. For a lay summery of our work, visit the BRC review of Jane's work published in Nature: 'Discovery of HIV 'invisibility cloak' reveals new treatment opportunities'


                                         


News

Read more about the Towers lab news on our News page.


Sierra Leone

The Towers lab has sent volunteers to West Africa to help with the international response to the Ebola outbreak. Jane Turner spent 5 weeks working in a diagnostic lab run by GOAL at their Ebola Treatment Centre in Port Loko.

Keystone

Tan presented at the 2015 Innate Immunity and Determinants of microbial Pathogenesis conference run by Keystone Symposia in Silverthorne, Colorado.

Mucosal surfaces, reproductive health and HIV in prevention research Workshop

Jane R and Teresa presented at the 2015 Mucosal surfaces, reproductive health and HIV in prevention research Workshop in Cape Town, South Africa.

Could I get Ebola?

Greg was interviewed by Dr Chris Van Tulleken in his documentary investigating the risk of an Ebola outbreak in the UK. How easy is it to catch? Could the virus improve it's methods of transmission? Watch 'Could I get Ebola?' on BBC iPlayer.

Feature

Doctors Chris and Xand Van Tulleken were featured in the Evening Standard's Life & Style Magazine. To read about Chris' circuitous route into HIV research, click here.


Award

Dr Chris Van Tulleken accepts the 2014 Max Perutz science writing prize


Dr Chris Van Tulleken celebrated winning the MRC’s Max Perutz Science Writing award at the Royal Institution in London this month. Visit our news page to read his article “Ex Africa Semper Aliquid Novo”.


Grant

Dr Jane Rasaiyaah has been awarded a grant by amfAR in their latest round of cure-focused research funding. Her work, in collaboration with Dr Leo James of Cambridge University, focuses on disrupting the ability of HIV to use a cellular protein to hide from the innate immune system by drugging and effectively uncloaking it.









We are funded by Senior Biomedical Research Fellowship from the Wellcome Trust No 090940 to Professor Greg Towers and also by: a European Research Council Advanced Award, a Medical Research Council confidence in concept award, a UCL Business proof of concept award, the National Institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre and the UCL MRC Centre for Medical Molecular Virology.


NHS National Institute for Health Research Logo
      blank      
Wellcome Trust Logo       European Research Council logo     Medical Research Council logo

Page last modified on 06 nov 14 17:59 by Jane Lorna Elizabeth Turner